Please find the interview of Prof. Patrizia Paterlini-Bréchot, Scientifc Advisor of Rarecells Diagnostics, regarding ISET® Blood Cytopathology tonight on Arte Tv
Article on Maire Claire available at the following adress: http://www.marieclaire.fr/,focus-sur-patrizia-paterlini-brechot-la-femme-qui-va-nous-sauver-du-cancer,819617.asp
Patrizia Paterlini-Bréchot, Scientific Advisor of Rarecells Diagnostics and inventor of “ISET® Blood Cytopathology”, interviewed by Inspir’her. http://www.inspirher.fr/patrizia-paterlini-brechot/
Please find in the video below the speech of Prof. Patrizia Paterlini-Bréchot, Scientific Advisor of Rarecells Diagnostics at Toulouse TEDx introducing the ISET® Blood Cytopathology (english subtitles availables).
Prof. Patrizia Paterlini-Bréchot will participate at the 7th International Conference on Tumor Microenvironment: Progression, Therapy & Prevention
As invited speaker, Prof. Paterlini-Brèchot will attend the PLENARY SESSION 6: Metastasis & the Metastatic Microenvironment (I) on October 14th 2015 at 17h15 with a lecture entitled: CIRCULATING TUMOR CELLS AND TUMOR MICROENVIRONMENT
Prof. Paterlini-Brèchot will attend the round table on September 22nd at 14:24 with a presentation entitled: SINGLE CELL GENETIC ANALYSIS HELPS VALIDATING CYTOPATHOLOGICAL IDENTIFICATION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH CLEAR CELLS RENAL CARCINOMA Programme:
ISET® Blood Cytopathology test is now avalable at ISET® Lab. For more information, visit http://www.isetbyrarecells.com/en/find-iset/
A key issue with cancers that continue to have lower patient survivability rates, such as lung cancer, cervical cancer and colorectal cancer, is that they are often not diagnosed until later stages. Many times this means that cancer is...
Circulating Tumor Cells (CTCs) are cells from a primary tumor that shed into a patient’s bloodstream. These cells can often be detected years before a cancer reaches metastasis, the later stages of cancer in which it becomes more difficult...